objectify < objective < objectives

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by objective

Number of relevant bibliographic references: 305.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2020)	C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine]	[A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
000024 (2020)	Joel Hirsh ; Patrick Wood ; Angela Keniston ; Dennis Boyle ; Itziar Quinzanos ; Liron Caplan ; Lisa Davis	Universal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients
000070 (2020)	Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]	Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000088 (2020)	N. Ghalandari ; R. J. E. M. Dolhain ; J. M. W. Hazes ; C. L. E. Siezen ; J. W. Van Der Laan ; H. J. M. J. Crijns ; E. P. Van Puijenbroek ; C. J. Van Der Woude	The pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
000104 (2020)	Wei Zhang [République populaire de Chine] ; Qiying Zhang [République populaire de Chine] ; Zihua Xuan [République populaire de Chine] ; Juan Liang [République populaire de Chine] ; Dongping Yang [République populaire de Chine] ; Meihuizi Ding [République populaire de Chine] ; Housheng Zhu [République populaire de Chine] ; Bo Su [République populaire de Chine] ; Xing Dai [République populaire de Chine] ; Xiaoyi Jia [République populaire de Chine]	The Protective Effect of Different Polar Solvent Extracts of Er Miao San on Rats with Adjuvant Arthritis
000118 (2020)	Gregory S. Calip [États-Unis] ; Pritesh R. Patel [États-Unis] ; Karen Sweiss [États-Unis] ; Zhaoju Wu [États-Unis] ; Jifang Zhou [États-Unis] ; Alemseged A. Asfaw [États-Unis] ; Sruthi Adimadhyam [États-Unis] ; Todd A. Lee [États-Unis] ; Brian C-H Chiu [États-Unis]	Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma.
000126 (2020)	E C Schwaneck [Allemagne] ; R. Renner [Allemagne] ; L. Junker [Allemagne] ; H-P Tony [Allemagne] ; S. Kleinert [Allemagne] ; M. Gernert [Allemagne] ; M. Schmalzing [Allemagne] ; O. Gadeholt [Allemagne]	T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy.
000154 (2020)	Marc L. Chretien [Canada] ; David G. Bailey [Canada] ; Linda Asher [Canada] ; Jeremy Parfitt [Canada] ; David Driman [Canada] ; Jamie Gregor [Canada] ; George K. Dresser [Canada]	Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study
000204 (2020)	Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis]	Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
000219 (2020)	Ayako Matsumura [Japon] ; Takuya Miyazaki [Japon] ; Takayoshi Tachibana [Japon] ; Taiki Ando [Japon] ; Megumi Koyama [Japon] ; Satoshi Koyama [Japon] ; Yoshimi Ishii [Japon] ; Hiroyuki Takahashi [Japon] ; Yuki Nakajima [Japon] ; Ayumi Numata [Japon] ; Wataru Yamamoto [Japon] ; Kenji Motohashi [Japon] ; Maki Hagihara [Japon] ; Kenji Matsumoto [Japon] ; Shin Fujisawa [Japon] ; Hideaki Nakajima [Japon]	Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study
000220 (2020)	Jamie E. Collins ; Fredrik D. Johansson ; Sara Gale ; Seoyoung Kim ; Swastina Shrestha ; David Sontag ; Jacklyn Stratton ; Huong Trinh ; Chang Xu ; Elena Losina ; Daniel H. Solomon	Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
000230 (2020)	Josef S. Smolen [Autriche] ; Jung-Yoon Choe [Corée du Sud] ; Michael E. Weinblatt [États-Unis] ; Paul Emery [Royaume-Uni] ; Edward Keystone [Canada] ; Mark C. Genovese [États-Unis] ; Gihyun Myung [Corée du Sud] ; Evelyn Hong [Corée du Sud] ; Inyoung Baek [Corée du Sud] ; Jeehoon Ghil [Corée du Sud]	Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis
000231 (2020)	Katie Bechman [Royaume-Uni] ; Mark Yates [Royaume-Uni] ; Sam Norton [Royaume-Uni] ; Andrew P. Cope [Royaume-Uni] ; James B. Galloway [Royaume-Uni]	Placebo Response in Rheumatoid Arthritis Clinical Trials.
000241 (2020)	Nick Bansback ; Jeffrey R. Curtis ; Jie Huang ; Zeling He ; Michael Evans ; Tracy Johansson ; Kaleb Michaud ; Gabriela Schmajuk ; Katherine P. Liao	Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
000292 (2020)	Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis]	Management and Treatment of COVID-19: The Chinese Experience
000327 (2020)	Jakob Einhaus [Allemagne] ; Ann-Christin Pecher [Allemagne] ; Elisa Asteriti [Allemagne] ; Hannes Schmid [Allemagne] ; Kathy-Ann Secker [Allemagne] ; Silke Duerr-Stoerzer [Allemagne] ; Hildegard Keppeler [Allemagne] ; Reinhild Klein [Allemagne] ; Corina Schneidawind [Allemagne] ; Joerg Henes [Allemagne] ; Dominik Schneidawind [Allemagne]	Inhibition of effector B cells by ibrutinib in systemic sclerosis
000328 (2020)	Mads Nikolaj Olesen ; Anna Wuolikainen ; Anna Christine Nilsson ; Martin Wirenfeldt ; Karin Forsberg ; Jonna Skov Madsen ; Soeren Thue Lillevang ; Ivan Brandslund ; Peter Munch Andersen ; Nasrin Asgari	Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
000330 (2020)	Cécile Dumaine [France] ; Sara Bekkar [France] ; Alexandre Belot [France] ; Natalia Cabrera [France] ; Salma Malik [France] ; Annette Von Scheven [Suisse] ; Aurelia Carbasse [France] ; Andreas Woerner [Suisse] ; Carine Wouters [Belgique] ; Kenza Bouayed ; Pascal Pillet [France] ; Silke Schroeder [Suisse] ; Michael Hofer [Suisse] ; Véronique Hentgen [France]	Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
000335 (2020)	Hiroto Minamino [Japon] ; Masao Katsushima [Japon] ; Tamami Yoshida [Japon] ; Motomu Hashimoto [Japon] ; Yoshihito Fujita [Japon] ; Mirei Shirakashi [Japon] ; Wataru Yamamoto [Japon] ; Kosaku Murakami [Japon] ; Koichi Murata [Japon] ; Kohei Nishitani [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Nobuya Inagaki [Japon] ; Shuichi Matsuda [Japon]	Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database
000357 (2020)	Zaiwei Song [République populaire de Chine] ; Yang Hu [République populaire de Chine] ; Siqian Zheng [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Rongsheng Zhao [République populaire de Chine]	Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience
000402 (2020)	Alexis Ogdie [États-Unis] ; Kurt De Vlam [Belgique] ; Iain B. Mcinnes [Royaume-Uni] ; Philip J. Mease [États-Unis] ; Philip Baer [Canada] ; Tatjana Lukic [États-Unis] ; David Gruben [États-Unis] ; Kenneth Kwok [États-Unis] ; Cunshan Wang [États-Unis] ; Ming-Ann Hsu [États-Unis] ; Anna Maniccia [États-Unis]	Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "objective" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "objective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    objective
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021